Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
NCT ID: NCT06597838
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
161876 participants
OBSERVATIONAL
2023-02-28
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients
NCT06857188
Early Prediction of Acute Kidney Injury in High Risk Patients After Non-cardiac Surgery
NCT03880110
Clinical Values of Automated Electronic Alert for Acute Kidney Injury
NCT02793167
The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients
NCT03736304
Prospective Validation of AKI Prediction
NCT06804200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Being diagnosed with end-stage renal disease (ESRD)
* Maintained on dialysis or had an initial Scr greater than or equal to 4.0 mg/dL at admission
* Developed AKI prior to admission or within 24 hours after admission
* Length of stay shorter than 24 hours
* Underwent kidney transplantation or nephrectomy during hospitalization
* With all Scr measurements lower than or equal to 0.6 mg/dL from 90 days prior to admission until discharge.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University First Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Yang
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Yang
Role: STUDY_DIRECTOR
Peking University First Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023[069-001]
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.